EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSEEUG00000010516
Gene Symbol: ATP1B2
4 External references
269 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSEEUG00000001457
Gene Symbol: ATP1B3
1 External references
296 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSEEUG00000011848
Gene Symbol: ATR
1 External references
207 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEEUG00000005125
Gene Symbol: BRAF
1 External references
220 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSEEUG00000009654
Gene Symbol: BCL2L1
4 External references
289 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSEEUG00000006401
Gene Symbol: BCR
1 External references
286 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSEEUG00000015649
Gene Symbol: BTK
1 External references
207 Possible Orthologues:

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSEEUG00000013605
Gene Symbol: CCR5
1 External references
152 Possible Orthologues:

C-X-C Chemokine Receptor Type 2

Ensembl ID : ENSEEUG00000001696
Gene Symbol: LOC103111465
2 External references
272 Possible Orthologues:

C-X-C Chemokine Receptor Type 2

Ensembl ID : ENSEEUG00000012836
Gene Symbol: LOC103110797
3 External references
272 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSEEUG00000006484
Gene Symbol: CFTR
1 External references
217 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSEEUG00000007857
Gene Symbol: TOP1
1 External references
273 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).